American Oncology Network, Inc. Quarterly Cost of Revenue in USD from Q3 2022 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
American Oncology Network, Inc. quarterly/annual Cost of Revenue history and growth rate from Q3 2022 to Q2 2024.
  • American Oncology Network, Inc. Cost of Revenue for the quarter ending June 30, 2024 was $405M, a 38.8% increase year-over-year.
  • American Oncology Network, Inc. Cost of Revenue for the twelve months ending June 30, 2024 was $1.39B.
  • American Oncology Network, Inc. annual Cost of Revenue for 2023 was $1.2B, a 13.5% increase from 2022.
  • American Oncology Network, Inc. annual Cost of Revenue for 2022 was $1.05B, a 21.8% increase from 2021.
  • American Oncology Network, Inc. annual Cost of Revenue for 2021 was $866M, a 31.5% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $1.39B $405M +$113M +38.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $1.27B $355M +$76.4M +27.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $1.2B $316M Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $311M +$43.2M +16.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $291M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $279M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q3 2022 $268M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.